Bioanalytical Services
 |
PharmaNet offers bioanalytical laboratory services through its subsidiaries: Anapharm, Anapharm Europe, Keystone Analytical and Taylor Technology.
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
 |
 |
 |
 |
 |
| Scopolamine | Gastrointestinal | LC/MS/MS | 50-10000 pg/mL | Human Plasma |
| Sertraline | Central Nervous System Agents | LC/MS/MS | 0.25-75 ng/mL | Human EDTA Plasma |
| Sertraline | Central Nervous System Agents | LC/MS/MS | 0.25-75 ng/mL | Human K3 EDTA Plasma |
| Sertraline | Central Nervous System Agents | LC/MS/MS | 0.1-50 ng/mL | Human EDTA Plasma |
| Sibutramine; N-Mono-desmethyl-sibutramine; N-di-desmethyl-sibutramine | Central Nervous System Agents | LC/MS/MS | 50-25000 pg/mL; 100-50000pg/mL; 100-50000pg/mL | Heparin Human Plasma |
| Sibutramine; N-mono-desmethyl-sibutramine; N-didesmethyl-sibutramine | Central Nervous System Agents | LC/MS/MS | 50-12500 pg/mL ; 100-5000 pg/mL ; 100-10000pg/mL | Human Sodium Heparinized Plasma |
| Sildenafil; Desmethyl sildenafil | Cardiovascular | LC/MS/MS | 2-500 ng/mL | Human Plasma |
| Sildenafil; Desmethyl Sildenafil | Cardiovascular | LC/MS/MS | 2-500 ng/mL ; 1-250 ng/mL | Human EDTA Plasma |
| Simvastatin and ß-Hydroxy Acid Simvastatin | Cardiovascular | LC/MS/MS | 100-20000 pg/mL; 100-5000 pg/nL | Human EDTA Plasma |
| Simvastatin; ß-Hydroxy Acid Simvastatin | Cardiovascular | LC/MS/MS | 100-20000 pg/mL; 100-5000 pg/mL | Human K3 EDTA Plasma |
| Sirolimus | Immunology | LC/MS/MS | 50-20000 pg/mL | Human Whole Blood |
| Sirolimus | Immunology | LC/MS/MS | 0.25-50 ng/mL | Human Whole Blood |
| Solifenacin | Genitourinary | LC/MS/MS | 100-20000 pg/mL | Human Plasma |
| Sorafenib | Oncology | LC/MS/MS | 10-5000 ng/mL | Human K2 EDTA Plasma |
| Spironolactone | Cardiovascular | LC/MS/MS | 1-200 ng/mL | Human EDTA Plasma |
| Spironolactone and Canrenone | Cardiovascular | LC/MS/MS | 0.5-100 ng/mL | Human EDTA Plasma |
| Stavudine | Infectious Disease | LC/MS/MS | 2.5-2000 ng/mL | Human EDTA Plasma |
| Sumatriptan | Pain | LC/MS/MS | 0.5-50 ng/mL | Human EDTA Plasma |
| Sumatriptan | Pain | LC/MS/MS | 0.5-100 ng/mL | Human Plasma |
| Sunitinib; n-desethyl-sunitinib | Oncology | LC/MS/MS | 0.25-100 ng/mL | Human EDTA Plasma |
| Synephrine | Cardiovascular, Ophtalmic | LC/MS/MS | 1-100 ng/mL | Human EDTA Plasma |